在异性造血细胞移植后,白血病通过遗传免疫逃生复发
Simona Pagliuca1,2,3, Carmelo Gurnari1,4, Colin Hercus5
1Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
减少人类白细胞抗原 (HLA) 多样性,既遗传又获得,增加了移植后白血病复发的风险. 这种免疫逃生机制阻碍了移植与白血病反应,导致疾病复发.
科学领域:
- 免疫遗传学 免疫遗传学
- 造血干细胞移植 造血干细胞移植
- 在瘤学瘤学.
背景情况:
- 异构性造血细胞移植是有效的骨髓瘤由于移植与白血病 (GvL) 反应.
- 白血病复发发生在免疫反应无法控制白血病增长时,需要对逃生机制进行研究.
研究的目的:
- 研究人类白细胞抗原 (HLA) 异质性在移植后白血病复发中的作用.
- 确定影响GvL反应失败的遗传因素.
主要方法:
- 对生殖线和体质HLA变异进行广泛的免疫遗传分析.
- 评估HLA等位基因的进化分歧和体质突变的获取.
主要成果:
- 减少生殖线HLA异质性和获得体质HLA缺陷增加了复发风险.
- 第二类HLA基因型的低进化分歧是复发的独立因素.
- 在I类和II类HLA基因中的体质突变有助于免疫系统从GvL控制中逃脱.
结论:
- 生殖线和体质HLA变化是移植后白血病逃逸的关键机制.
- 了解这些HLA驱动的逃生途径可以为预防移植后复发的策略提供信息.
更多相关视频
14:51Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype
Published on: June 17, 2022
11:55Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
Published on: March 14, 2011
相关概念视频
Treatment Resistant Cancers
Cell-mediated Immune Responses
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
